newsfilter
← Latest News
GlobeNewswire·

Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943

PALO ALTO, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (NASDAQ:VINC)("Vincerx"), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through